Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Eledon Pharmaceuticals and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and AstraZeneca PLC.
Diversification Opportunities for Eledon Pharmaceuticals and AstraZeneca PLC
The 3 months correlation between Eledon and AstraZeneca is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Eledon Pharmaceuticals and AstraZeneca PLC
Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 5.71 times more return on investment than AstraZeneca PLC. However, Eledon Pharmaceuticals is 5.71 times more volatile than AstraZeneca PLC ADR. It trades about 0.14 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.2 per unit of risk. If you would invest 244.00 in Eledon Pharmaceuticals on March 6, 2024 and sell it today you would earn a total of 36.00 from holding Eledon Pharmaceuticals or generate 14.75% return on investment over 90 days.
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, AstraZeneca PLC displayed solid returns over the last few months and may actually be approaching a breakup point.